Arkolith/Insider Trading/CVKD/Form 4

Pham Quang X

Chairman, CEO and Interim CFO, Director, 10% OwnerCadrenal Therapeutics, Inc. (CVKD) · full profile →Form 4 · filed Jun 18, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$13K
Net Open-Market Flow
-$13K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 17, 2026Sell(S)513$3.16$2K129K
Jun 16, 2026Sell(S)4K$3.18$11K129K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-26-070248) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML